NCT04704232

Study of Safety, Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

Prospective,Double-blind,Randomized,Placebo-controlled Study of Safety,Efficacy, and Pharmacokinetics of Topical ACD440 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: AlzeCure Pharma · Industry
• Sex: All
• Age: 18 Years – 64 Years
• Healthy volunteers: Accepted

Summary

Phase 1 b placebo-controlled study in healthy volunteers to study safety, efficacy and pharmacokinetics of Topical ACD440 on normal skin, skin optimized for penetration and skin exposed to ultraviolet radiation

Detailed description

This is an exploratory study, no primary or secondary endpoints are being defined.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	ACD440	Double blind, parallel within subject comparison
DRUG	PLAC	Double blind, parallel within subject comparison

Timeline

• Start date: 2021-01-12
• Primary completion: 2021-03-10
• Completion: 2021-03-10
• First posted: 2021-01-11
• Last updated: 2021-11-16

Locations

1 site across 1 country: Sweden